Alternative Splicing & Introns Flashcards
Splicing Components
Within introns, a donor site (5’ end of the intron), a branch site (near the 3’ end of the intron) and an acceptor site (3’ end of the intron) are required for splicing. The splice donor site includes an almost invariant sequence GU at the 5’ end of the intron. The splice acceptor site at the 3’ end of the intron terminates the intron with an almost invariant AG sequence. Further upstream is the branchpoint, which includes an adenine nucleotide involved in lariat formation
Self-Splicing
- The 2’OH of a specific adenosine in the intron attacks the 5’ splice site, thereby forming the lariat
- The 3’OH of the 5’ exon triggers the second transesterification at the 3’ splice site, thereby joining the exons together.
Spliceosome
- formed of 5 small nuclear RNAs associating with proteins to form small nuclear ribonucleic particles
- snRNAs: U1,2,4,5,6
- snRNPs + accessory proteins = spliceosomes
- attach to transcript in sequential manner
Assembly of Spliceosome
- U1/2 assemble onto pre-mRNA in cotranscriptional manner
- U1 binds 5’ end of intron (donor site)
- U2 binds 3’ intron end (acceptor site) - U1/2 snRNPs interact with each other to form prespliceosome (complex A)
- 2 exons brought together - preassembled tri snRNP U4,6,5 recruited to form complex B
- complex B forms catalytically active complex
Activity of Spliceosome
- complex B carries out the first catalytic step of splicing generating complex C containing free exon 1 and intron-exon 2 lariat intermediate
- complex c undergoes additional rearrangements and carries out second catalytic step
- ligates 5’ exon to 3’ exon
- post splice complex with spliced exons and lariat intron - release of lariat and spliced mRNA
Alternative Splicing
- one transcript can have 2 or more splicing pathways
- related but different mRNAs
- exons retained or skipped
- introns excised or retained
- 5’ & 3’ splice site positions moved to change length
DSCAM Splicing
- membrane anchored cell surface protein with noles in neuronal development
- 24 exons permit 38,016 protein variants
Splicing Regulation
- can play a role in regulation supplementing transcriptional control
- insertion/deletion of specific domains controlling gene expression
- regulated antibody and neuropeptide production
- act of splicing coupled to nuclear export (intron presence reduces export)
- regulates balance of function to nonfunctional RNAs
Effect of mRNA and Protein
- rate of translation
- mRNA degradation
- insertion/deletion of residues or domains
- truncation with stop codons
- changes localisation of protein
- change affinity of protein
5’ transcript splice types
- 5’ transcript ends differ
- differential start sites causes different processing and different splicing complexes
- strength of donor sites differs
eg. mouse a-amylase has 2 start sites forming a salivary amylase or liver amylase
3’ transcript splice types
- 3’ ends differ
- different polyA sites used for termination
eg. immunoglobin chains of antibodies have different stop sites either coding for an additional TM anchor or making free antibodies
Middle portions splice types
- not explained by differential promoter use or cleavage
- internal exon combinations give permutations
eg. troponin T gene in skeletal muscle - spliced in 64 different ways due to tissue specific splicing factors acting on pre-mRNA
Tissue Specific Splicing Factor
- recognise cis-acting sequences in transcript
- promote or inhibit splice sites in different cases
SXL in Drosophila
- autoregulates own splicing
- in absence exon 2 splices with exon 1 to form a stop codon and a truncated male protein
- sxl binds intron and inhibits factors at splice acceptor site
- exon 3 included for a functional sxl protein
- initial sxl expression caused by imbalance of X via autosomes
Tra in Drosophila
- females have sxl protein
- sxl binds at proximal splice sites in intron 1 preventing U2AF binding
- binds cryptic site in exon 2: splicing out of stop codon
- males have splicing from 1 exon to the next
- no SxL so short protein formed (non functional)